HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

promyelocytic leukemia-retinoic acid receptor alpha fusion oncoprotein

selectively expressed in acute promyelocytic leukemia cells; recognized by T lymphocytes; amino acid sequence given in first source; product of a functionally altered retinoic acid receptor alpha gene
Also Known As:
PML-RARalpha; PML-RARalpha protein
Networked: 264 relevant articles (22 outcomes, 16 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Chen, Zhu: 7 articles (02/2010 - 11/2002)
2. Ley, Timothy J: 6 articles (02/2007 - 09/2003)
3. Kogan, Scott C: 5 articles (12/2007 - 02/2003)
4. Chen, Z: 5 articles (01/2007 - 01/2001)
5. Gallagher, R E: 5 articles (04/2006 - 01/2000)
6. Jing, Yongkui: 5 articles (09/2005 - 08/2002)
7. Müller-Tidow, Carsten: 4 articles (06/2010 - 12/2004)
8. de Thé, H: 4 articles (02/2009 - 06/2001)
9. Zhu, J: 4 articles (09/2008 - 06/2001)
10. Tenen, Daniel G: 4 articles (02/2008 - 02/2003)

Related Diseases

1. Acute Promyelocytic Leukemia
2. Leukemia
3. Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
4. Residual Neoplasm
5. Hematologic Neoplasms (Hematological Malignancy)

Related Drugs and Biologics

1. Tretinoin (Retinoic Acid)
2. arsenic trioxide (Trisenox)
3. retinoic acid receptor alpha
4. Messenger RNA (mRNA)
5. Aligeron (AS 2)
6. Valproic Acid (Valproate, Semisodium)
7. RNA-Directed DNA Polymerase (Reverse Transcriptase)
8. Arsenic
9. Histone Deacetylase Inhibitors
10. RNA (Ribonucleic Acid)

Related Therapies and Procedures

1. Drug Therapy (Chemotherapy)
2. Transplants (Transplant)
3. Stem Cell Transplantation
4. Salvage Therapy
5. Bone Marrow Transplantation (Transplantation, Bone Marrow)